11hon MSN
Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results